Try GOLD - Free

HOPE AMIDST HESITATION?

Healthcare Radius

|

March 2024

The Union Finance Minister Nirmala Sitharaman's Budget 2024-25 elicited a mixed response from healthcare sub-segments.

HOPE AMIDST HESITATION?

India's Interim Budget 2024-25, presented by Finance Minister Nirmala Sitharaman, has sparked a lively debate within the healthcare community. While applauding specific initiatives, many leaders call for a broader vision and increased budgetary allocation.

The unveiling of India's Interim Budget 2024-25 by Finance Minister Nirmala Sitharaman has elicited a spectrum of reactions from healthcare leaders across the nation. While some laud the government's focus on preventive measures, medical education, and women's health, others voice concerns about insufficient budgetary allocations and the absence of a holistic healthcare strategy.

PREVENTIVE MEASURES GET THUMBS UP, WITH CAVEATS

The inclusion of HPV vaccination for girls aged 9-14 in the Ayushman Bharat scheme has met with enthusiastic approval. "This proactive initiative will significantly contribute to reducing the disease burden and improving healthcare in our nation," commends Dr Mayank Aggarwal, Consultant Medical Oncologist, Venkateshwar Hospitals, New Delhi. Dr Devavrat Arya, Senior Director at Max Hospital, echoes this sentiment, highlighting the importance of spreading awareness about the vaccine's safety.

"This visionary step prioritizes public health through preventive measures against life-threatening diseases,” says Dr Nisha Bhatnagar, Medical Director of Infinite Fertility. Dr Shafiq AM, Co-founder of Trilife Hospital, agrees with this sentiment, calling it a “welcome move” to tackle a critical issue. However, Dr Digvijay Singh, Ophthalmologist and Director of Noble Eye Care, urges for more focus on preventive measures compared to other G20 nations.

MORE STORIES FROM Healthcare Radius

Healthcare Radius

Healthcare Radius

VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM

Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.

time to read

1 mins

December 2025

Healthcare Radius

Healthcare Radius

A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026

The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.

time to read

12 mins

December 2025

Healthcare Radius

Healthcare Radius

FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA

From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.

time to read

6 mins

December 2025

Healthcare Radius

ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US

Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS

Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL

Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH

Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS

By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”

time to read

7 mins

December 2025

Healthcare Radius

Healthcare Radius

MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM

Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.

time to read

1 min

December 2025

Listen

Translate

Share

-
+

Change font size